B-intervention	0	11	Mindfulness
I-intervention	11	12	-
I-intervention	12	17	based
I-intervention	18	27	cognitive
I-intervention	28	35	therapy
I-intervention	36	37	(
I-intervention	37	41	MBCT
I-intervention	41	42	)
O	43	45	is
O	46	50	cost
O	50	51	-
O	51	60	effective
O	61	69	compared
O	70	72	to
O	73	74	a
B-control	75	79	wait
I-control	79	80	-
I-control	80	84	list
I-control	85	92	control
O	93	96	for
B-condition	97	107	persistent
I-condition	108	112	pain
O	113	115	in
O	116	121	women
O	122	129	treated
O	130	133	for
O	134	141	primary
O	142	148	breast
O	149	155	cancer
O	155	156	-
O	156	163	Results
O	164	168	from
O	169	170	a
O	171	181	randomized
O	182	192	controlled
O	193	198	trial
O	198	199	.

O	200	202	To
O	203	214	investigate
O	215	218	the
O	219	223	cost
O	223	224	-
O	224	237	effectiveness
O	238	240	of
O	241	252	mindfulness
O	252	253	-
O	253	258	based
O	259	268	cognitive
O	269	276	therapy
O	277	278	(
O	278	282	MBCT
O	282	283	)
O	284	292	compared
O	293	295	to
O	296	297	a
O	298	302	wait
O	302	303	-
O	303	307	list
O	308	315	control
O	316	321	group
O	322	325	for
O	326	330	pain
O	331	333	in
B-eligibility	334	339	women
I-eligibility	340	347	treated
I-eligibility	348	351	for
I-eligibility	352	358	breast
I-eligibility	359	365	cancer
O	365	366	.

O	367	368	A
O	369	374	total
O	375	377	of
B-total-participants	378	381	129
O	382	387	women
O	388	392	were
O	393	401	randomly
O	402	411	allocated
O	412	414	to
O	415	419	MBCT
O	420	422	or
O	423	424	a
O	425	429	wait
O	429	430	-
O	430	434	list
O	435	442	control
O	443	448	group
O	448	449	.

O	450	453	The
O	454	461	primary
O	462	469	outcome
O	470	473	was
O	474	477	the
B-outcome-Measure	478	485	minimal
I-outcome-Measure	486	496	clinically
I-outcome-Measure	497	506	important
I-outcome-Measure	507	517	difference
I-outcome-Measure	518	519	(
I-outcome-Measure	519	523	MCID
I-outcome-Measure	523	524	)
I-outcome-Measure	525	527	on
I-outcome-Measure	528	532	pain
I-outcome-Measure	533	542	intensity
O	543	544	(
O	544	545	≥
O	545	546	2
O	547	552	point
O	553	562	reduction
O	563	565	on
O	566	568	an
O	569	571	11
O	571	572	-
O	572	577	point
O	578	585	Numeric
O	586	592	Rating
O	593	598	Scale
O	598	599	)
O	599	600	.

O	601	609	Analyses
O	610	614	were
O	615	624	conducted
O	625	629	from
O	630	633	the
O	634	640	health
O	641	645	care
O	646	652	system
O	653	664	perspective
O	665	668	and
O	669	677	included
O	678	682	data
O	683	685	on
O	686	692	health
O	693	697	care
O	698	709	utilization
O	710	713	and
O	714	718	pain
O	719	729	medication
O	730	739	retrieved
O	740	744	from
O	745	753	national
O	754	764	registries
O	765	768	for
O	769	772	the
O	773	779	period
O	780	784	from
O	785	793	baseline
O	794	795	(
O	795	797	T1
O	797	798	)
O	799	801	to
O	802	803	6
O	804	810	months
O	811	827	postintervention
O	828	829	(
O	829	831	T4
O	831	832	)
O	832	833	.

O	834	843	Bootstrap
O	844	855	simulations
O	856	860	were
O	861	865	used
O	866	868	to
O	869	877	estimate
O	878	888	confidence
O	889	898	intervals
O	899	902	for
O	903	906	the
O	907	918	incremental
O	919	923	cost
O	924	927	and
O	928	934	effect
O	935	943	measures
O	943	944	,
O	945	948	and
O	949	953	cost
O	953	954	-
O	954	967	effectiveness
O	968	981	acceptability
O	982	988	curves
O	988	989	.

O	990	992	In
O	993	1004	sensitivity
O	1005	1013	analyses
O	1013	1014	,
O	1015	1017	we
O	1018	1026	replaced
O	1027	1035	dropouts
O	1036	1040	with
O	1041	1045	last
O	1045	1046	-
O	1046	1057	observation
O	1057	1058	-
O	1058	1065	carried
O	1065	1066	-
O	1066	1073	forward
O	1074	1077	and
O	1078	1084	tested
O	1085	1097	consequences
O	1098	1100	of
O	1101	1107	higher
O	1108	1113	costs
O	1114	1116	of
O	1117	1120	the
O	1121	1133	intervention
O	1133	1134	.

O	1135	1138	The
O	1139	1151	intervention
O	1152	1156	cost
O	1157	1160	was
O	1161	1164	240
O	1164	1165	€
O	1166	1169	per
O	1170	1181	participant
O	1181	1182	.

O	1183	1186	The
B-outcome	1187	1194	average
I-outcome	1195	1200	total
I-outcome	1201	1205	cost
O	1206	1210	from
O	1211	1213	T1
O	1214	1216	to
O	1217	1219	T4
O	1220	1222	in
O	1223	1226	the
O	1227	1231	MBCT
O	1232	1237	group
O	1238	1241	was
B-iv-cont-mean	1242	1246	1706
I-iv-cont-mean	1246	1247	€
O	1248	1256	compared
O	1257	1261	with
B-cv-cont-mean	1262	1266	2436
I-cv-cont-mean	1266	1267	€
O	1268	1270	in
O	1271	1274	the
O	1275	1282	control
O	1283	1288	group
O	1289	1290	(
O	1290	1294	mean
O	1295	1305	difference
O	1305	1306	:
O	1307	1310	729
O	1310	1311	€
O	1311	1312	,
O	1313	1314	P
O	1315	1316	=
O	1317	1318	.
O	1318	1320	07
O	1320	1321	)
O	1321	1322	.

O	1323	1327	More
O	1328	1333	women
O	1334	1336	in
O	1337	1340	the
O	1341	1345	MBCT
O	1346	1351	group
O	1352	1353	(
O	1353	1354	N
O	1354	1355	:
B-iv-bin-abs	1355	1357	19
O	1357	1358	/
B-intervention-participants	1358	1360	36
O	1360	1361	;
B-iv-bin-percent	1362	1364	52
I-iv-bin-percent	1364	1365	.
I-iv-bin-percent	1365	1366	8
I-iv-bin-percent	1366	1367	%
O	1367	1368	)
O	1369	1373	than
O	1374	1376	in
O	1377	1380	the
O	1381	1388	control
O	1389	1394	group
O	1395	1396	(
O	1396	1397	N
O	1397	1398	:
B-cv-bin-abs	1398	1400	14
O	1400	1401	/
B-control-participants	1401	1403	48
O	1403	1404	;
B-cv-bin-percent	1405	1407	29
I-cv-bin-percent	1407	1408	.
I-cv-bin-percent	1408	1409	2
I-cv-bin-percent	1409	1410	%
O	1410	1411	)
B-outcome	1412	1420	achieved
I-outcome	1421	1423	an
I-outcome	1424	1428	MCID
I-outcome	1429	1431	in
I-outcome	1432	1436	pain
I-outcome	1437	1446	intensity
O	1447	1448	(
O	1448	1450	OR
O	1450	1451	=
O	1451	1452	2
O	1452	1453	.
O	1453	1455	71
O	1455	1456	,
O	1457	1458	P
O	1459	1460	=
O	1461	1462	.
O	1462	1464	03
O	1464	1465	)
O	1465	1466	.

O	1467	1470	The
O	1471	1475	MBCT
O	1476	1479	was
O	1480	1484	cost
O	1484	1485	-
O	1485	1494	effective
O	1495	1499	with
O	1500	1501	a
O	1502	1513	probability
O	1514	1516	of
O	1517	1519	85
O	1519	1520	%
O	1521	1525	with
O	1526	1527	a
O	1528	1533	value
O	1534	1536	of
O	1537	1539	an
O	1540	1550	additional
O	1551	1556	women
O	1557	1566	achieving
O	1567	1571	MCID
O	1572	1575	set
O	1576	1578	to
O	1579	1583	zero
O	1584	1592	remained
O	1593	1597	cost
O	1597	1598	-
O	1598	1607	effective
O	1608	1612	with
O	1613	1614	a
O	1615	1626	probability
O	1627	1629	of
O	1630	1632	70
O	1632	1633	%
O	1634	1636	to
O	1637	1639	82
O	1639	1640	%
O	1641	1645	when
O	1646	1653	smaller
O	1654	1660	effect
O	1661	1664	and
O	1665	1671	higher
O	1672	1676	MBCT
O	1677	1682	costs
O	1683	1687	were
O	1688	1695	assumed
O	1695	1696	.

O	1697	1700	Our
O	1701	1708	results
O	1709	1716	suggest
O	1717	1721	that
O	1722	1726	MBCT
O	1727	1729	is
O	1730	1731	a
O	1732	1736	cost
O	1736	1737	-
O	1737	1746	effective
O	1747	1751	pain
O	1752	1764	intervention
O	1765	1768	for
O	1769	1774	women
O	1775	1782	treated
O	1783	1786	for
O	1787	1793	breast
O	1794	1800	cancer
O	1800	1801	.

O	1802	1808	Future
O	1809	1816	studies
O	1817	1822	could
O	1823	1830	include
O	1831	1838	utility
O	1839	1847	measures
O	1847	1848	,
O	1849	1857	indirect
O	1858	1863	costs
O	1863	1864	,
O	1865	1868	and
O	1869	1875	active
O	1876	1883	control
O	1884	1890	groups
O	1891	1893	to
O	1894	1902	increase
O	1903	1906	the
O	1907	1923	generalizability
O	1924	1927	and
O	1928	1937	pragmatic
O	1938	1943	value
O	1944	1946	of
O	1947	1950	the
O	1951	1958	results
O	1958	1959	.
